Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY

v3.21.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)
Total
Series A, Preferred Stock
Series B, Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2019   757,770 2,666,667 3,252,371    
Balance, amount at Dec. 31, 2019 $ 19,200,949 $ 757 $ 2,667 $ 3,252 $ 133,932,615 $ (114,738,342)
Conversion of 11,875 preferred shares to 1,255 common shares, shares   (11,875) 1,255    
Conversion of 11,875 preferred shares to 1,255 common shares, amount 0 $ (12) $ 0 $ 1 11 0
Shares issued - registered offerings - net of offering costs, shares   110,053    
Shares issued - registered offerings - net of offering costs, amount 399,675 $ 0 $ 0 $ 111 399,564 0
Stock-based compensation 6,085 0 0 0 6,085 0
Net Loss (2,264,086) $ 0 $ 0 $ 0 0 (2,264,086)
Shares issued to consultant & directors for services, amount 0          
Balance, shares at Mar. 31, 2020   745,895 2,666,667 3,363,679    
Balance, amount at Mar. 31, 2020 17,342,623 $ 745 $ 2,667 $ 3,364 134,338,275 (117,002,428)
Balance, shares at Dec. 31, 2020   699,878 2,666,667 6,567,110    
Balance, amount at Dec. 31, 2020 17,207,557 $ 699 $ 2,667 $ 6,567 146,353,232 (129,155,608)
Stock-based compensation 60,068 0 0 0 60,068 0
Net Loss (2,011,988) $ 0 $ 0 $ 0 0 (2,011,988)
Shares issued to consultant & directors for services, shares   24,200    
Shares issued to consultant & directors for services, amount 69,690 $ 0 $ 0 $ 24 69,666 0
Balance, shares at Mar. 31, 2021   699,878 2,666,667 6,591,310    
Balance, amount at Mar. 31, 2021 $ 15,325,327 $ 699 $ 2,667 $ 6,591 $ 146,482,966 $ (131,167,596)